Skip to main content
. 2018 Aug 22;12:2601–2609. doi: 10.2147/DDDT.S170676

Figure 4.

Figure 4

Effect of different BUD formulations on TNBS-induced colitis rat model.

Notes: (A) MPO activity, (B) body weight (n=6). *p⩽0.05 vs BUD-ES100/PLGA NPs.

Abbreviations: BUD, budesonide; TNBS, 2,4,6-trinitrobenzenesulfonic acid; MPO, myeloperoxidase; ES100, Eudragit S100; PLGA, poly(lactic-co-glycolic acid); NPs, nanoparticles.